Ameriprise’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39M Sell
609,141
-29,215
-5% -$1.92M 0.01% 1073
2026
Q1
$45.4M Buy
638,356
+180,619
+39% +$14.2M 0.01% 920
2025
Q4
$37.6M Buy
457,737
+187,985
+70% +$14.6M 0.01% 1038
2025
Q3
$20.3M Sell
269,752
-142,792
-35% -$10.7M ﹤0.01% 1389
2025
Q2
$30.6M Sell
412,544
-94,674
-19% -$6.59M 0.01% 1121
2025
Q1
$40.9M Sell
507,218
-8,767
-2% -$753K 0.01% 938
2024
Q4
$40.3M Buy
515,985
+144,495
+39% +$12.3M 0.01% 942
2024
Q3
$34.8M Sell
371,490
-30,502
-8% -$2.56M 0.01% 1029
2024
Q2
$31.3M Buy
401,992
+32,173
+9% +$2.62M 0.01% 1021
2024
Q1
$33.6M Sell
369,819
-8,521
-2% -$709K 0.01% 993
2023
Q4
$29.3M Sell
378,340
-2,290,355
-86% -$160M 0.01% 1057
2023
Q3
$182M Buy
2,668,695
+1,221,436
+84% +$88.9M 0.06% 320
2023
Q2
$118M Sell
1,447,259
-487,126
-25% -$38.9M 0.04% 458
2023
Q1
$159M Buy
+1,934,385
New +$138M 0.05% 356

Other funds holding GEHC

Ameriprise's GEHC Position: Q2 2026 in Review

Ameriprise reduced its GE HealthCare (GEHC) stake by 4.6% in Q2 2026, selling an estimated $1.92M and leaving 609,141 shares worth $39M. The position accounts for 0.01% of the portfolio, ranked #1073.

Ameriprise first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $182M in Q3 2023. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Ameriprise held 609,141 shares of GE HealthCare worth $39M as of Q2 2026.
  • Ameriprise sold 29,215 GE HealthCare shares in Q2 2026, an estimated $1.92M.
  • GE HealthCare made up 0.01% of Ameriprise's portfolio in Q2 2026, its #1073 holding.
  • Ameriprise first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Ameriprise's GE HealthCare position peaked at $182M in Q3 2023.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.